IRIS PubliCatt

Lombardi, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.500
EU - Europa 1.124
AS - Asia 553
AF - Africa 14
OC - Oceania 6
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.206
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.484
SE - Svezia 356
IT - Italia 217
CN - Cina 196
SG - Singapore 195
PL - Polonia 115
IE - Irlanda 96
DE - Germania 80
FR - Francia 78
ID - Indonesia 63
IN - India 53
FI - Finlandia 52
RU - Federazione Russa 33
GB - Regno Unito 25
BE - Belgio 19
HK - Hong Kong 13
CA - Canada 12
NL - Olanda 11
ES - Italia 10
IR - Iran 10
CI - Costa d'Avorio 9
CH - Svizzera 6
UA - Ucraina 6
CZ - Repubblica Ceca 5
JP - Giappone 5
AU - Australia 4
TW - Taiwan 4
LT - Lituania 3
VN - Vietnam 3
AT - Austria 2
CL - Cile 2
EU - Europa 2
MA - Marocco 2
MX - Messico 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PK - Pakistan 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BR - Brasile 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
IM - Isola di Man 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 3.206
Salva come PNG Salva come JPEG
Città #
Chandler 476
Singapore 156
Ashburn 120
Warsaw 114
New York 104
Dublin 93
Milan 71
Jakarta 63
San Mateo 55
Helsinki 48
Beijing 42
Boston 41
Princeton 41
Rome 41
Marseille 39
Wilmington 34
Ann Arbor 25
Fairfield 25
Moscow 25
Nanjing 24
Woodbridge 20
Brussels 19
Seattle 17
Jacksonville 16
Houston 15
Pune 15
Cambridge 14
Augusta 12
Cattolica 12
Los Angeles 12
Redwood City 12
Dearborn 10
Abidjan 9
Amsterdam 9
Hong Kong 9
London 9
Andover 7
Nanchang 7
Frankfurt am Main 6
Hangzhou 6
Norwalk 6
Ottawa 6
Santa Clara 6
Toronto 6
Turin 6
Bologna 5
Columbus 5
Guangzhou 5
Jinan 5
Kish 5
Shenyang 5
Brno 4
Carate Brianza 4
Edinburgh 4
Falkenstein 4
Jiaxing 4
Lancaster 4
Madrid 4
Mountain View 4
Tianjin 4
Tokyo 4
Alcalá de Henares 3
Atlanta 3
Bremen 3
Cagliari 3
Changsha 3
Chicago 3
Chongqing 3
Dong Ket 3
Düsseldorf 3
Fort Worth 3
Hefei 3
Leawood 3
Paris 3
Phoenix 3
Sacramento 3
Springfield 3
Alexandria 2
Bern 2
Boardman 2
Brea 2
Castano Primo 2
Cedar Knolls 2
Central District 2
Changchun 2
Chennai 2
Chiusi 2
Ciampino 2
Fuzhou 2
Hanover 2
Las Rozas de Madrid 2
Lawrence 2
Manerbio 2
Mexico City 2
Milton 2
Munich 2
Nuremberg 2
Panama City 2
Poggio A Caiano 2
Redmond 2
Totale 2.067
Salva come PNG Salva come JPEG
Nome #
Evaluation of the effect of a floxed Neo cassette within the dystroglycan (Dag1) gene 261
Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study 100
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine versus the 23-valent polysaccharide vaccine in unvaccinated HIV-infected adults: A pilot, prospective controlled study 95
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 89
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART 87
Psychological distress during the initial stage of the COVID-19 pandemic in an italian population living with HIV: An online survey 83
Sarilumab use in severe SARS-CoV-2 pneumonia 80
Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practice 78
HIV-Related Internalized Stigma and Patient Health Engagement Model in an Italian Cohort of People Living With HIV 78
An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy 76
Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line 73
Lamivudine-based maintenance antiretroviral therapies in patients living with HIV-1 with suppressed HIV RNA: derivation of a predictive score for virological failure 72
Evolution of cellular HIV DNA levels in virologically suppressed patients switching to dolutegravir/lamivudine versus maintaining a triple regimen: a prospective, longitudinal, matched, controlled study 72
Pretreatment HIV drug resistance and treatment failure in non-Italian HIV-1-infected patients enrolled in ARCA 72
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV 71
HIV DNA Decay in a Treatment-Naive Patient Starting Dolutegravir Plus Lamivudine with Resistance Mutations to Integrase Inhibitors: A Case Report 71
Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV 71
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 69
Trends of hospitalisations rates in a cohort of HIV-infected persons followed in an Italian hospital from 1998 to 2016 68
Use of Long-Acting Therapies for HIV Care in Italy: Are People Living with HIV Prepared for Change? A Cross-Sectional Study 66
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: A retrospective study from the clinical practice 62
Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV-1 replication 61
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 61
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir–rilpivirine in clinical practice 61
Long-Term Serological Response to 13-Valent Pneumococcal Conjugate Vaccine Versus 23-Valent Polysaccharide Vaccine in HIV-Infected Adults 60
Seroprevalence of sars-cov-2 antibodies in hiv-infected patients in rome, italy during the covid-19 outbreak 60
Short Communication: Comparing Lamivudine+Dolutegravir and Bictegravir/Emtricitabine/Tenofovir Alafenamide as Switch Strategies: Preliminary Results from Clinical Practice 59
Risk of Tumor Onset in HIV+ Patients on Two-Drug Regimens: A Cohort Study in an Italian Hospital 59
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy 57
No evidence of SARS-CoV-2 circulation in HIV-infected patients between December 2019 and February 2020 in Rome, Italy 55
Real-Life Safety of Doravirine in Treatment-Experienced, Virologically Suppressed PLWHIV 54
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy 51
Evaluation of doravirine-based regimen population target in a large Italian clinical center 50
Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection 49
Inflammation markers in virologically suppressed HIV-Infected patients after switching to dolutegravir plus lamivudine vs continuing triple therapy: 48-week results in real-life setting 47
Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database 45
Home Care Assistance: Has Covid-19 had an Impact on the Complex Management of HIV Patients? 44
Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients 44
Functional associations between polymorphic regions of the human 3'IgH locus and COVID-19 disease 43
Long-term maintenance of virologic suppression in native and migrant HIV-1 naïve patients: an Italian cohort study 41
Quantification of total hiv dna as a marker to measure viral reservoir: Methods and potential implications for clinical practice 41
Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors 36
Short Communication: Efficacy and Safety of Dolutegravir plus Lamivudine as a First-Line Regimen in Clinical Practice 36
Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections 36
No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference 35
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 34
Impact of pre-existent drug resistance on virological efficacy of single-tablet regimens in people living with HIV 32
Comparison of HIV-DNA decay in naive patients starting dolutegravir plus lamivudine or dolutegravir-based triple therapy 32
Dynamics of total and intact HIV-1 DNA in virologically suppressed patients switching to DTG- or ATV-based dual therapy 28
Impact of resistance mutations on efficacy of dolutegravir plus rilpivirine or plus lamivudine as maintenance regimens: a cohort study 22
Compound heterozygosity for mutations in LMNA in a patient with a myopathic and lipodystrophic mandibuloacral dysplasia type A phenotype 20
Nasopharingeal bacterial and fungal colonization in HIV-positive versus HIV-negative adults 18
The association between stigma and wellbeing in an Italian cohort of PLWH: The role of social support and personal factors 16
Letter to the Editor: Real-Life Experience of Long-Acting Cabotegravir-Rilpivirine Combination in a Person Living with HIV with Detectable Viremia: A Case Report 15
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study 14
Characteristics of mental health interventions in a cohort of Italian PLWH over the last five years: impact of HIV disease and outbreak of COVID-19 pandemic 14
Increased release and activity of matrix metalloproteinase-9 in patients with mandibuloacral dysplasia type A, a rare premature ageing syndrome 14
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed 13
Response to BNT162b2 mRNA COVID-19 vaccine of ART-experienced people living with HIV: a prospective analysis from a single-center study in Rome, Italy 13
Changes in Metabolic Profile in PLWHIV Switching to Doravirine-Based Regimen 11
A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops 10
Clinical presentation of human monkeypox virus infection during the 2022 outbreak: descriptive case series from a large italian Research Hospital 9
Factors Associated with Low-Level Viremia in People Living with HIV in the Italian Antiviral Response Cohort Analysis Cohort: A Case-Control Study 8
Totale 3.302
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.621
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020136 0 0 0 0 0 0 17 10 15 8 80 6
2020/2021144 25 11 5 7 14 10 9 2 12 12 30 7
2021/2022464 10 3 10 51 10 6 38 78 14 40 56 148
2022/20231.177 163 179 93 173 75 139 63 92 134 8 46 12
2023/2024666 16 143 17 63 23 134 46 15 18 25 96 70
2024/2025424 21 18 155 52 101 71 6 0 0 0 0 0
Totale 3.302